STOCK TITAN
  1. Home
  2. Sec-filings
  3. ALHC
  4. [Form 4] Alignment Healthcare, Inc. Insider Trading Activity

Alignment Healthcare (ALHC) president sells 30,000 shares under Rule 10b5-1 plan

Filing Impact
(Very High)
Filing Sentiment
(Negative)
Form Type
4

Rhea-AI Filing Summary

Alignment Healthcare, Inc. president Dawn Christine Maroney reported an open-market sale of 30,000 shares of common stock at a weighted-average price of $19.5475 per share. The transaction was executed under a Rule 10b5-1 trading plan adopted on May 22, 2025. After this sale, she directly holds 947,313 shares, indicating a large remaining ownership position.

Positive

  • None.

Negative

  • None.
Insider Maroney Dawn Christine
Role President
Sold 30,000 shs ($586K)
Type Security Shares Price Value
Sale Common Stock 30,000 $19.5475 $586K
Holdings After Transaction: Common Stock — 947,313 shares (Direct, null)
Footnotes (1)
  1. Date of Rule 10b5-1 plan adoption: 05/22/2025 The reported price in column 4 is a weighted-average price. Shares were sold in multiple transactions at a per share price ranging from $19.19 to $19.80. The reporting person undertakes to provide to Alignment Healthcare, Inc., any security holder of Alignment Healthcare, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each price within the range.
Shares sold 30,000 shares Open-market sale of common stock on June 15, 2026
Weighted-average sale price $19.5475 per share Average price for 30,000 shares sold
Post-transaction holdings 947,313 shares Directly held by Dawn Christine Maroney after sale
Price range of trades $19.19–$19.80 per share Range of individual sale prices within the transaction
Rule 10b5-1 plan adoption date May 22, 2025 Date the trading plan governing this sale was adopted
Rule 10b5-1 plan regulatory
"Date of Rule 10b5-1 plan adoption: 05/22/2025"
A Rule 10b5-1 plan is a prearranged, written schedule that lets corporate insiders buy or sell company stock at set times or amounts, even if they later learn material nonpublic information. Think of it like setting an automatic thermostat for trades: it creates a clear record that trades were planned in advance, reducing the risk of insider-trading accusations and helping investors trust that insider transactions are routine rather than based on secret information.
weighted-average price financial
"The reported price in column 4 is a weighted-average price."
Weighted-average price is the average of multiple prices where each price is counted according to its size or importance—larger trades carry more weight than smaller ones, like averaging course grades by credit hours. It matters to investors because it gives a more realistic picture of the true price paid or received, helping assess trade execution, compare performance, calculate cost basis, and value positions more accurately than a simple average.
open-market sale financial
"transaction_action: open-market sale"
An open-market sale is when a shareholder sells existing shares directly on a public exchange to any willing buyer, rather than through a private deal. Think of it like putting goods on a busy market stall where price is set by supply and demand; for investors it matters because such sales increase available supply, can put short-term downward pressure on the stock price, and signal changes in liquidity or investor confidence.
Form 4 regulatory
"INSIDER FILING DATA (Form 4):"
Form 4 is a official document that company insiders, such as executives or major shareholders, file with regulators whenever they buy or sell company shares. It provides transparency about how those with inside knowledge are trading, helping investors see if insiders are confident in the company's prospects or may be selling for personal reasons. This information can influence investor decisions by revealing insiders' perspectives on the company's value.
See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google
Add on Google
Form 4 Insider Transactions: What Each Field Means →
SEC Form 4
FORM 4UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940
OMB APPROVAL
OMB Number:3235-0287
Estimated average burden
hours per response:0.5
Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).
X
Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.
1. Name and Address of Reporting Person*
Maroney Dawn Christine
(Last)(First)(Middle)
1100 W. TOWN & COUNTRY RD.
SUITE 1600
(Street)
ORANGE CALIFORNIA 92868
(City)(State)(Zip)
UNITED STATES
(Country)		2. Issuer Name and Ticker or Trading Symbol
Alignment Healthcare, Inc. [ ALHC ] 		5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)
Director10% Owner
XOfficer (give title below)Other (specify below)
President
2a. Foreign Trading Symbol
3. Date of Earliest Transaction (Month/Day/Year)
06/15/2026		6. Individual or Joint/Group Filing (Check Applicable Line)
XForm filed by One Reporting Person
Form filed by More than One Reporting Person
4. If Amendment, Date of Original Filed (Month/Day/Year)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3) 2. Transaction Date (Month/Day/Year)2A. Deemed Execution Date, if any (Month/Day/Year)3. Transaction Code (Instr. 8) 4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5) 5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4) 6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 7. Nature of Indirect Beneficial Ownership (Instr. 4)
CodeVAmount(A) or (D)Price
Common Stock06/15/2026S(1)30,000D$19.5475(2)947,313D
Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned
(e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3) 2. Conversion or Exercise Price of Derivative Security 3. Transaction Date (Month/Day/Year)3A. Deemed Execution Date, if any (Month/Day/Year)4. Transaction Code (Instr. 8) 5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5) 6. Date Exercisable and Expiration Date (Month/Day/Year)7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4) 8. Price of Derivative Security (Instr. 5) 9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4) 10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 11. Nature of Indirect Beneficial Ownership (Instr. 4)
CodeV(A)(D)Date ExercisableExpiration DateTitleAmount or Number of Shares
Explanation of Responses:
1. Date of Rule 10b5-1 plan adoption: 05/22/2025
2. The reported price in column 4 is a weighted-average price. Shares were sold in multiple transactions at a per share price ranging from $19.19 to $19.80. The reporting person undertakes to provide to Alignment Healthcare, Inc., any security holder of Alignment Healthcare, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each price within the range.
Remarks:
/s/ Christopher J. Joyce, as Attorney-in-Fact, for Dawn C. Maroney06/15/2026
** Signature of Reporting PersonDate
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)

Source: View Original Filing on SEC EDGAR

FAQ

What insider transaction did Alignment Healthcare (ALHC) report for Dawn Christine Maroney?

Alignment Healthcare reported that president Dawn Christine Maroney sold 30,000 shares of common stock in an open-market transaction. The shares were sold at a weighted-average price of $19.5475 per share, as part of a previously adopted Rule 10b5-1 trading plan.

At what price did Dawn Christine Maroney sell Alignment Healthcare (ALHC) shares?

She sold 30,000 Alignment Healthcare shares at a weighted-average price of $19.5475 per share. The filing notes individual trades occurred in a range between $19.19 and $19.80 per share, with detailed trade information available on request from the company or regulators.

How many Alignment Healthcare (ALHC) shares does Dawn Christine Maroney hold after the sale?

After the reported transaction, Dawn Christine Maroney directly holds 947,313 shares of Alignment Healthcare common stock. This indicates she retains a significant equity position in the company even after selling 30,000 shares in the disclosed open-market transaction.

Was the Alignment Healthcare (ALHC) insider sale under a Rule 10b5-1 plan?

Yes. The filing states the transaction was executed under a Rule 10b5-1 trading plan adopted on May 22, 2025. Such pre-arranged plans allow insiders to systematically sell shares according to preset instructions, helping separate trading decisions from day-to-day company news.

What does the weighted-average price mean in the Alignment Healthcare (ALHC) Form 4?

The weighted-average price of $19.5475 reflects multiple trades executed between $19.19 and $19.80 per share. The insider undertook to provide full details of the number of shares sold at each price within that range to the company, any security holder, or the SEC staff upon request.